Metastatic

Oncology·MeSH: Neoplasms

990 drugs in development·204 companies·3 clinical trials

Drug Pipeline by Phase

Approved(70)

Drug	Company
abiraterone	Mersana Therapeutics, Inc. (MRSN)
abiraterone	DR REDDYS LABORATORIES LTD (RDY)
abiraterone	Aptinyx Inc. (APTX)
abiraterone	Mylan II B.V. (MYL)
ABRAXANE	ImmunityBio, Inc. (IBRX)
aBSI (Automated Bone Scan Index)	Lantheus Holdings, Inc. (LNTH)
afinitor	Novartis AG (NVS)
alymsys	Amneal Pharmaceuticals, Inc. (AMRX)
Aybintio (SB8)	Organon & Co. (OGN)
bicalutamide	Aptinyx Inc. (APTX)
bicalutamide	SUNSET ISLAND GROUP (SUN)
BRACAnalysis CDx	MYRIAD GENETICS INC (MYGN)
braftovi	ARRAY BIOPHARMA INC (ARRY)
calcium gluconate in	Amneal Pharmaceuticals, Inc. (AMRX)
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
cerianna	GE HealthCare Technologies Inc. (GEHC)
COMETRIQ	EXELIXIS, INC. (EXEL)
Cyramza	ELI LILLY & Co (LLY)
Cyramza®	ELI LILLY & Co (LLY)
docetaxel	PFIZER INC (PFE)
docetaxel	Amneal Pharmaceuticals, Inc. (AMRX)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
emrelis	AbbVie Inc. (ABBV)
enzalutamide	Aptinyx Inc. (APTX)
enzalutamide	X4 Pharmaceuticals, Inc (XFOR)
eribulin	DR REDDYS LABORATORIES LTD (RDY)
Erivedge	CURIS INC (CRIS)
gavreto	RIGEL PHARMACEUTICALS INC (RIGL)
ibrance	PFIZER INC (PFE)
ibtrozi	Nuvation Bio Inc. (NUVB)
Inluriyo	ELI LILLY & Co (LLY)
jevtana kit	Sanofi (SNY)
keytruda qlex	Merck & Co., Inc. (MRK)
KIMMTRAK	Immunocore Holdings plc (IMCR)
kisqali femara co-pack	Novartis AG (NVS)
krazati	Mirati Therapeutics, Inc. (MRTX)
krazati	BRISTOL MYERS SQUIBB CO (BMY)
loqtorzi	Coherus Oncology, Inc. (CHRS)
lorbrena	PFIZER INC (PFE)
MARGENZA	MACROGENICS INC (MGNX)
mektovi	ARRAY BIOPHARMA INC (ARRY)
nilutamide	ANI PHARMACEUTICALS INC (ANIP)
ogivri	Mylan II B.V. (MYL)
onivyde	MERRIMACK PHARMACEUTICALS INC (MACK)
Ontruzant (SB3)	Organon & Co. (OGN)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
paclitaxel	Mylan II B.V. (MYL)
pedmark	FENNEC PHARMACEUTICALS INC. (FENC)
pemetrexed	DR REDDYS LABORATORIES LTD (RDY)
pemfexy	EAGLE PHARMACEUTICALS, INC. (EGRX)
portrazza	ELI LILLY & Co (LLY)
proleukin	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
tecelra	Adaptimmune Therapeutics PLC (ADAP)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
trodelvy	Immunome Inc. (IMNM)
tukysa	Seagen Inc. (SGEN)
tykerb	Novartis AG (NVS)
unloxcyt	Fortress Biotech Inc. (FBIO)
unloxcyt	Checkpoint Therapeutics, Inc. (CKPT)
unloxcyt	Fortress Biotech Inc. (FBIO)
Verzenio®	ELI LILLY & Co (LLY)
vizimpro	PFIZER INC (PFE)
vykoura	Kaya Holdings, Inc. (KAYS)
xgeva	AMGEN INC (AMGN)
yonsa	SUNSET ISLAND GROUP (SUN)
zaltrap	Sanofi (SNY)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)	Merus N.V. (MRUS)
ziihera	Zymeworks Inc. (ZYME)
Ziihera	Jazz Pharmaceuticals plc (JAZZ)
ZYNYZ	MACROGENICS INC (MGNX)

Phase 3(264)

Drug	Company
[177Lu]Lu-DOTA-TATE	Novartis AG (NVS)
[68ga]ga-psma-11	Novartis AG (NVS)
[Lu-177]-PNT2002	ELI LILLY & Co (LLY)
177lu-pnt2002	POINT Biopharma Global Inc. (PNT)
177lu-psma-617	ENDOCYTE INC (ECYT)
177lu-tlx591	Telix Pharmaceuticals Ltd (TLPPF)
177lu-tlx591	Telix Pharmaceuticals Limited (TLX)
aaa617	Novartis AG (NVS)
abiraterone	Telix Pharmaceuticals Limited (TLX)
abiraterone	GH Research PLC (GHRS)
abiraterone	Telix Pharmaceuticals Ltd (TLPPF)
Abiraterone	ELI LILLY & Co (LLY)
Abiraterone acetate	Merck & Co., Inc. (MRK)
abp 234	AMGEN INC (AMGN)
acasunlimab	Genmab A/S (GMAB)
administration of lymphodepletion	GH Research PLC (GHRS)
adoptive cell therapy with til	GH Research PLC (GHRS)
amezalpat	Tempest Therapeutics, Inc. (TPST)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
Amivantamab	Merus N.V. (MRUS)
amivantamab iv	GH Research PLC (GHRS)
androgen deprivation therapy	CHINA PHARMA HOLDINGS, INC. (CPHI)
Androgen-deprivation Therapy	Myovant Sciences Ltd. (MYOV)
Apalutamide	Crinetics Pharmaceuticals, Inc. (CRNX)
ardt	Novartis AG (NVS)
ARDT	Novartis AG (NVS)
ARM C FOLFIRI	IGM Biosciences, Inc. (IGMS)
arx788	Ambrx Biopharma Cayman, Inc. (AMAM)
Atirmociclib	Olema Pharmaceuticals, Inc. (OLMA)
avelumab	CG Oncology, Inc. (CGON)
avelumab	GH Research PLC (GHRS)
Avelumab	Merck & Co., Inc. (MRK)
Avelumab	IGM Biosciences, Inc. (IGMS)
azd0171	ASTRAZENECA PLC (AZN)
AZD0516	ASTRAZENECA PLC (AZN)
AZD0754	ASTRAZENECA PLC (AZN)
AZD2014	ASTRAZENECA PLC (AZN)
azd2265	ASTRAZENECA PLC (AZN)
AZD2275	ASTRAZENECA PLC (AZN)
AZD2284	ASTRAZENECA PLC (AZN)
AZD2287	ASTRAZENECA PLC (AZN)
AZD2936	ASTRAZENECA PLC (AZN)
AZD5069	ASTRAZENECA PLC (AZN)
AZD5305	ASTRAZENECA PLC (AZN)
azd7789	ASTRAZENECA PLC (AZN)
azd8359	ASTRAZENECA PLC (AZN)
AZD9150	ASTRAZENECA PLC (AZN)
Background Chemotherapy	Merus N.V. (MRUS)
BET Bromodomain Inhibitor ZEN-3694	Merus N.V. (MRUS)
Biweekly FOLFIRI	IGM Biosciences, Inc. (IGMS)
BMS-986365	KYNTRA BIO INC. (KYNB)
Bria-IMT™	BriaCell Therapeutics Corp. (BCTX)
Cabazitaxel	ASTRAZENECA PLC (AZN)
Cabazitaxel 60 mg Solution for Injection	KYNTRA BIO INC. (KYNB)
Cabozantinib	Royalty Pharma plc (RPRX)
Cabozantinib S-malate	Royalty Pharma plc (RPRX)
Cabozantinib S-malate	Merus N.V. (MRUS)
Capivasertib	ASTRAZENECA PLC (AZN)
cemiplimab	GH Research PLC (GHRS)
Ceralasertib	ASTRAZENECA PLC (AZN)
Cetrelimab	KYNTRA BIO INC. (KYNB)
cetuximab	AVEO PHARMACEUTICALS, INC. (AVEO)
cetuximab	Novartis AG (NVS)
cetuximab	GH Research PLC (GHRS)
Cetuximab	BeOne Medicines Ltd. (ONC)
Cetuximab	FATE THERAPEUTICS INC (FATE)
Cetuximab	BRISTOL MYERS SQUIBB CO (BMY)
Ciprofloxacin 500g	UNITED THERAPEUTICS Corp (UTHR)
CMAB009	IGM Biosciences, Inc. (IGMS)
dabrafenib	Novartis AG (NVS)
Dacarbazine	Filana Therapeutics Inc. (FLNA)
Dacarbazine	ENANTA PHARMACEUTICALS INC (ENTA)
Darolutamide	ARS Pharmaceuticals, Inc. (SPRY)
Darolutamide plus ADT treatment	Royalty Pharma plc (RPRX)
datopotamab deruxtecan	ASTRAZENECA PLC (AZN)
Drug	Summit Therapeutics Inc. (SMMT)
eftilagimod alfa	Immutep Limited (IMMP)
eftilagimod alfa	IMMUTEP Ltd (PRRUF)
Eftilagimod Alfa	Immutep Limited (IMMP)
elacestrant	Radius Health, Inc. (RDUS)
Enfortumab Vedotin	Merck & Co., Inc. (MRK)
Ensartinib	Merus N.V. (MRUS)
Ensartinib	ENANTA PHARMACEUTICALS INC (ENTA)
Enzalutamide	ARS Pharmaceuticals, Inc. (SPRY)
Enzalutamide	ELI LILLY & Co (LLY)
Enzalutamide	Merck & Co., Inc. (MRK)
Enzalutamide	Myovant Sciences Ltd. (MYOV)
ERAS-0015 in combination	Erasca, Inc. (ERAS)
ERAS-4001 in combination	Erasca, Inc. (ERAS)
Erbitux®	Amneal Pharmaceuticals, Inc. (AMRX)
Eribulin	Merus N.V. (MRUS)
Eribulin	Jazz Pharmaceuticals plc (JAZZ)
Eribulin Mesylate	Merus N.V. (MRUS)
Eribulin Mesylate	Arbutus Biopharma Corp (ABUS)
erlotinib 150/100 mg	ASTRAZENECA PLC (AZN)
Evolocumab	UNITED THERAPEUTICS Corp (UTHR)
ficerafusp alfa (formerly BCA101)	Bicara Therapeutics Inc. (BCAX)
ficlatuzumab	AVEO PHARMACEUTICALS, INC. (AVEO)
First-line Chemotherapy	Merus N.V. (MRUS)
Fludrocortisone acetate	Merck & Co., Inc. (MRK)
FOLFIRI	Amneal Pharmaceuticals, Inc. (AMRX)
FOLFIRI Protocol	IGM Biosciences, Inc. (IGMS)
folfiri regimen	AMGEN INC (AMGN)
FOLFIRI+cetuximab	IGM Biosciences, Inc. (IGMS)
FOLFIRINOX	IGM Biosciences, Inc. (IGMS)
FOLFOX	Amneal Pharmaceuticals, Inc. (AMRX)
FOLFOX	KYNTRA BIO INC. (KYNB)
FOLFOX	IGM Biosciences, Inc. (IGMS)
FOLFOX-4	IGM Biosciences, Inc. (IGMS)
FOLFOX-7	IGM Biosciences, Inc. (IGMS)
FOLFOX+QL1706+Cetuximab	KYNTRA BIO INC. (KYNB)
Fruquintinib	IGM Biosciences, Inc. (IGMS)
Fruquintinib Combined With Chemotherapy	IGM Biosciences, Inc. (IGMS)
furmonertinib	ArriVent BioPharma, Inc. (AVBP)
GDC-9545	ENANTA PHARMACEUTICALS INC (ENTA)
Giredestrant	ENANTA PHARMACEUTICALS INC (ENTA)
GnRH Agonist	ENANTA PHARMACEUTICALS INC (ENTA)
gonadotropin-releasing hormone analogues	NOVARTIS AG (NVSEF)
goserelin	Novartis AG (NVS)
Goserelin	Novartis AG (NVS)
high dose il-2	GH Research PLC (GHRS)
HRS-4357 injection	KYNTRA BIO INC. (KYNB)
Hydrocortisone	Merck & Co., Inc. (MRK)
Hydrocortisone	Merus N.V. (MRUS)
IBI351, cetuximab β combined with FOLFIRI	IGM Biosciences, Inc. (IGMS)
ifx-2.0	TuHURA Biosciences, Inc./NV (HURA)
ifx2.0	TuHURA Biosciences, Inc./NV (HURA)
IMA203	ENANTA PHARMACEUTICALS INC (ENTA)
IMA203	Filana Therapeutics Inc. (FLNA)
IMA203	PTC THERAPEUTICS, INC. (PTCT)
IMA203	Merus N.V. (MRUS)
Immune Globulin Subcutaneous, 20% Solution	ENANTA PHARMACEUTICALS INC (ENTA)
Inavolisib	ENANTA PHARMACEUTICALS INC (ENTA)
intravenous tislelizumab	BeOne Medicines Ltd. (ONC)
Intravenous Tislelizumab	BeOne Medicines Ltd. (ONC)
Ipatasertib	ENANTA PHARMACEUTICALS INC (ENTA)
ivospemin	PANBELA THERAPEUTICS, INC. (SNBP)
JDQ443	Novartis AG (NVS)
Lartesertib	Merck & Co., Inc. (MRK)
lasofoxifene	LeonaBio, Inc. (LONA)
lazertinib	GH Research PLC (GHRS)
Lazertinib	ENANTA PHARMACEUTICALS INC (ENTA)
Lenvatinib	Merck & Co., Inc. (MRK)
leucovorin	GH Research PLC (GHRS)
leucovorin	BeOne Medicines Ltd. (ONC)
Leucovorin	BeOne Medicines Ltd. (ONC)
Leucovorin	Amneal Pharmaceuticals, Inc. (AMRX)
Leucovorin	BRISTOL MYERS SQUIBB CO (BMY)
Leucovorin Calcium	Amneal Pharmaceuticals, Inc. (AMRX)
leuprorelin	PFIZER INC (PFE)
LHRH Agonist	ENANTA PHARMACEUTICALS INC (ENTA)
lifileucel	ENANTA PHARMACEUTICALS INC (ENTA)
lifileucel	Merus N.V. (MRUS)
lifileucel	PTC THERAPEUTICS, INC. (PTCT)
lifileucel	Filana Therapeutics Inc. (FLNA)
luteinizing hormone-releasing hormone analog	GH Research PLC (GHRS)
Lymphodepleting chemotherapy	Merus N.V. (MRUS)
Lymphodepletion	Filana Therapeutics Inc. (FLNA)
MEDI4736	ASTRAZENECA PLC (AZN)
MEDI5752	ASTRAZENECA PLC (AZN)
Metronidazole	Myovant Sciences Ltd. (MYOV)
mevrometostat	PFIZER INC (PFE)
mFOLFOXIRI	IGM Biosciences, Inc. (IGMS)
MK-0472	Merck & Co., Inc. (MRK)
MK-1084	Merck & Co., Inc. (MRK)
Naporafenib	Erasca, Inc. (ERAS)
New Formulation of Niraparib and Abiraterone Acetate	Janux Therapeutics, Inc. (JANX)
Niraparib	Myovant Sciences Ltd. (MYOV)
Niraparib	Janux Therapeutics, Inc. (JANX)
Niraparib	ARS Pharmaceuticals, Inc. (SPRY)
nis793	Novartis AG (NVS)
Olaparib	KYNTRA BIO INC. (KYNB)
Olaparib	Merck & Co., Inc. (MRK)
Opevesostat	Merck & Co., Inc. (MRK)
Opevesostat	Merus N.V. (MRUS)
Osimertinib	ENANTA PHARMACEUTICALS INC (ENTA)
Palazestrant	Olema Pharmaceuticals, Inc. (OLMA)
palazestrant (formerly known as OP-1250)	Olema Pharmaceuticals, Inc. (OLMA)
palazestrant (OP-1250)	Olema Pharmaceuticals, Inc. (OLMA)
panitumumab	GH Research PLC (GHRS)
Panitumumab	IGM Biosciences, Inc. (IGMS)
PARP Inhibitors and Other Systemic Agents	KYNTRA BIO INC. (KYNB)
pasritamig	GH Research PLC (GHRS)
pds0101	PDS Biotechnology Corp (PDSB)
pemetrexed	Crinetics Pharmaceuticals, Inc. (CRNX)
pemetrexed	Incyte Corp. (INCY)
Pemetrexed	ELI LILLY & Co (LLY)
Pemetrexed	ENANTA PHARMACEUTICALS INC (ENTA)
Pemetrexed	BRISTOL MYERS SQUIBB CO (BMY)
Pertuzumab	ASTRAZENECA PLC (AZN)
PF-07220060 CDK4 inhibitor	Merus N.V. (MRUS)
Physician's choice chemotherapy	ASTRAZENECA PLC (AZN)
platinum-based chemotherapy	ArriVent BioPharma, Inc. (AVBP)
pnt2002	POINT Biopharma Global Inc. (PNT)
PNT2002	Lantheus Holdings, Inc. (LNTH)
Radium Chloride Ra-223	KYNTRA BIO INC. (KYNB)
radium-223	ASTRAZENECA PLC (AZN)
ramucirumab	GH Research PLC (GHRS)
Ramucirumab	ASTRAZENECA PLC (AZN)
regn15505	REGENERON PHARMACEUTICALS, INC. (REGN)
regn4336	REGENERON PHARMACEUTICALS, INC. (REGN)
regn5678	REGENERON PHARMACEUTICALS, INC. (REGN)
regorafenib	IGM Biosciences, Inc. (IGMS)
Rescue Medication	Merus N.V. (MRUS)
Rescue medications for chemotherapy	Merus N.V. (MRUS)
retifanlimab	Incyte Corp. (INCY)
rigosertib	TRAWS PHARMA, INC. (ONTX)
Rilvegostomig	ASTRAZENECA PLC (AZN)
rocapuldencel-t	ARGOS THERAPEUTICS INC (ARGS)
RPH-002	Amneal Pharmaceuticals, Inc. (AMRX)
Rucaparib	KYNTRA BIO INC. (KYNB)
sacituzumab govitecan	IMMUNOMEDICS INC (IMMU)
sacituzumab govitecan	Phoenix Life Sciences International Limited. (PLSI)
Sacituzumab Govitecan	Arbutus Biopharma Corp (ABUS)
Single-agent chemotherapy	Merus N.V. (MRUS)
Sintilimab	IGM Biosciences, Inc. (IGMS)
Sintilimab injection	KYNTRA BIO INC. (KYNB)
Standard Chemotherapy	BioNTech SE (BNTX)
standard management	Crinetics Pharmaceuticals, Inc. (CRNX)
Standard systemic therapy	IGM Biosciences, Inc. (IGMS)
subcutaneous tislelizumab	BeOne Medicines Ltd. (ONC)
Subcutaneous Tislelizumab	BeOne Medicines Ltd. (ONC)
sugemalimab	EQRx, Inc. (EQRX)
sunvozertinib	Merus N.V. (MRUS)
Supportive care measures	Merck & Co., Inc. (MRK)
surzebiclimab	BeOne Medicines Ltd. (ONC)
SYS6010	Merus N.V. (MRUS)
Systemic therapy	IGM Biosciences, Inc. (IGMS)
t-dxd	ASTRAZENECA PLC (AZN)
tak-188	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-188	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-280	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-280	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-788	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-788	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-981	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-981	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Talazoparib	PFIZER INC (PFE)
tas6417	CG Oncology, Inc. (CGON)
Taxane	ASTRAZENECA PLC (AZN)
temozolomide	ENANTA PHARMACEUTICALS INC (ENTA)
tesetaxel	Odonate Therapeutics, Inc. (ODT)
timing to initiate the adjuvant FOLFOX chemotherapy	Merus N.V. (MRUS)
Tiragolumab	IGM Biosciences, Inc. (IGMS)
Trametinib	Erasca, Inc. (ERAS)
Trametinib	Novartis AG (NVS)
treatment adaptation guided by ctDNA variation	Crinetics Pharmaceuticals, Inc. (CRNX)
treatment arm	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
tsr-042	TESARO, Inc. (TSRO)
Tyrosine kinase Inhibitors	ENANTA PHARMACEUTICALS INC (ENTA)
vepdegestrant	ARVINAS, INC. (ARVN)
Vincristine	Black Diamond Therapeutics, Inc. (BDTX)
vinflunine	Phoenix Life Sciences International Limited. (PLSI)
Vinorelbine	Jazz Pharmaceuticals plc (JAZZ)
Vinorelbine Tartrate	Merus N.V. (MRUS)
Vinorelbine Tartrate	ENANTA PHARMACEUTICALS INC (ENTA)
Xaluritamig	Xencor Inc (XNCR)
Young TIL	Filana Therapeutics Inc. (FLNA)
zilovertamab	Oncternal Therapeutics, Inc. (ONCT)
zipalertinib	Cullinan Therapeutics, Inc. (CGEM)
zongertinib	Merus N.V. (MRUS)

Phase 2(243)

Drug	Company
[177Lu]Lu-DOTATATE	Novartis AG (NVS)
350 mg leronlimab	CytoDyn Inc. (CYDY)
5 FU bolus	IGM Biosciences, Inc. (IGMS)
5 FU continuous	IGM Biosciences, Inc. (IGMS)
68ga-psma-11	Novartis AG (NVS)
68Ga-PSMA-11	Novartis AG (NVS)
700 mg leronlimab	CytoDyn Inc. (CYDY)
AAA617	Novartis AG (NVS)
Abiraterone	Novartis AG (NVS)
Abiraterone	Crinetics Pharmaceuticals, Inc. (CRNX)
Abiraterone acetate	UNITED THERAPEUTICS Corp (UTHR)
ABT-869	AbbVie Inc. (ABBV)
ABV-1703	ABVC BIOPHARMA, INC. (ABVC)
ad-rts-hil-12	Alaunos Therapeutics, Inc. (TCRT)
adxs-psa	OLD AYALA, INC (AYLA)
ADXS-PSA	Ayala Pharmaceuticals, Inc. (ADXS)
Aldesleukin	Twist Bioscience Corp (TWST)
Aldesleukin	Filana Therapeutics Inc. (FLNA)
ALLO-316	Allogene Therapeutics, Inc. (ALLO)
ALLO-647	Allogene Therapeutics, Inc. (ALLO)
amcenestrant	Sanofi (SNY)
amcenestrant	Sanofi (SNYNF)
Amivantamab	ENANTA PHARMACEUTICALS INC (ENTA)
androgen receptor signal inhibitor	GH Research PLC (GHRS)
Arm A - Olaparib	IGM Biosciences, Inc. (IGMS)
Avelumab	NEKTAR THERAPEUTICS (NKTR)
azd5305 microtracer	ASTRAZENECA PLC (AZN)
AZD9574	ASTRAZENECA PLC (AZN)
BDTX-1535	Black Diamond Therapeutics, Inc. (BDTX)
BGB-53038	BeOne Medicines Ltd. (ONC)
Biweekly FOLFIRI	Merus N.V. (MRUS)
Biweekly FOLFIRI	KYNTRA BIO INC. (KYNB)
Biweekly FOLFIRI	REGENXBIO Inc. (RGNX)
Biweekly Modified FOLFOX6	REGENXBIO Inc. (RGNX)
Biweekly Modified FOLFOX6	IGM Biosciences, Inc. (IGMS)
Biweekly Modified FOLFOX6	KYNTRA BIO INC. (KYNB)
Brigatinib	Merus N.V. (MRUS)
BT8009	BICYCLE THERAPEUTICS PLC (BCYC)
Budigalimab	AbbVie Inc. (ABBV)
BXCL701	BioXcel Therapeutics, Inc. (BTAI)
BXCL701	Merck & Co., Inc. (MRK)
Cabazitaxel	Janux Therapeutics, Inc. (JANX)
cabozantinib	CG Oncology, Inc. (CGON)
Cabozantinib S-malate	ENANTA PHARMACEUTICALS INC (ENTA)
CAPOX	Merus N.V. (MRUS)
Cemiplimab	Amneal Pharmaceuticals, Inc. (AMRX)
Ceterizine	ASTRAZENECA PLC (AZN)
Cetrelimab	ENANTA PHARMACEUTICALS INC (ENTA)
Cetrelimab	Merus N.V. (MRUS)
Cetrelimab	Royalty Pharma plc (RPRX)
cetuximab	PFIZER INC (PFE)
Cetuximab	ImmunityBio, Inc. (IBRX)
Chlorhexidine	Structure Therapeutics Inc. (GPCR)
Clindamycin	Structure Therapeutics Inc. (GPCR)
Clobetasol	Structure Therapeutics Inc. (GPCR)
CTX-009	Compass Therapeutics, Inc. (CMPX)
Cyclophophamide	Allogene Therapeutics, Inc. (ALLO)
cylembio	IO Biotech, Inc. (IOBT)
Darolutamide	Novartis AG (NVS)
DFMO	UNITED THERAPEUTICS Corp (UTHR)
Direct Oral Anticoagulant	Structure Therapeutics Inc. (GPCR)
Dostarlimab	Merus N.V. (MRUS)
Doxycycline	Structure Therapeutics Inc. (GPCR)
eflornithine	PANBELA THERAPEUTICS, INC. (SNBP)
Elraglusib Injection	ACTUATE THERAPEUTICS, INC. (ACTU)
Elraglusib Oral Tablet	ACTUATE THERAPEUTICS, INC. (ACTU)
Emavusertib	ADMA BIOLOGICS, INC. (ADMA)
Encorafenib	Novartis AG (NVS)
Enhertu	KYNTRA BIO INC. (KYNB)
Ensartinib	ADMA BIOLOGICS, INC. (ADMA)
Enzalutamide	UNITED THERAPEUTICS Corp (UTHR)
Enzalutamide	Crinetics Pharmaceuticals, Inc. (CRNX)
Enzalutamide	Novartis AG (NVS)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
eribulin	Cardiff Oncology, Inc. (CRDF)
eribulin	ALX ONCOLOGY HOLDINGS INC (ALXO)
eribulin	CG Oncology, Inc. (CGON)
Etoposide	Merck & Co., Inc. (MRK)
etrumadenant	Arcus Biosciences, Inc. (RCUS)
etrumadenant	Arcus Biosciences, Inc. (RCUS)
etrumadenant	Coherus Oncology, Inc. (CHRS)
Etrumadenant	Arcus Biosciences, Inc. (RCUS)
evorpacept	Cardiff Oncology, Inc. (CRDF)
evorpacept	ALX ONCOLOGY HOLDINGS INC (ALXO)
evorpacept	CG Oncology, Inc. (CGON)
FG-3246	KYNTRA BIO INC. (KYNB)
FLOX	ENANTA PHARMACEUTICALS INC (ENTA)
Floxuridine	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Fludarabine	Twist Bioscience Corp (TWST)
Fludarabine	Allogene Therapeutics, Inc. (ALLO)
fludarabine as part of lymphodepletion	GH Research PLC (GHRS)
folfiri	Novartis AG (NVS)
folfiri	ASTRAZENECA PLC (AZN)
folfiri	ONCOLYTICS BIOTECH INC (ONCY)
FOLFIRI	Merus N.V. (MRUS)
FOLFIRI regimen	REGENXBIO Inc. (RGNX)
Folfirinox	Merus N.V. (MRUS)
folfirinox alone	Salspera, Inc. (TKVA)
FOLFOX	ENANTA PHARMACEUTICALS INC (ENTA)
FOLFOX regimen	IGM Biosciences, Inc. (IGMS)
FOLFOX regimen	KYNTRA BIO INC. (KYNB)
Fosifloxuridine Nafalbenamide	IGM Biosciences, Inc. (IGMS)
fpi-2265	Fusion Pharmaceuticals Inc. (FUSN)
GnRH analog	KYNTRA BIO INC. (KYNB)
GSK5764227	Merus N.V. (MRUS)
Hydroxychloroquine	IGM Biosciences, Inc. (IGMS)
i-131-1095	PROGENICS PHARMACEUTICALS INC (PGNX)
i-131-1095	ARS Pharmaceuticals, Inc. (SPRY)
ifosfamide	Black Diamond Therapeutics, Inc. (BDTX)
Immune Checkpoint Inhibitors	ENANTA PHARMACEUTICALS INC (ENTA)
Inavolisib	Crinetics Pharmaceuticals, Inc. (CRNX)
Inavolisib	IGM Biosciences, Inc. (IGMS)
Inavolisib	KYNTRA BIO INC. (KYNB)
incb001158	Incyte Corp. (INCY)
induction therapy	Novartis AG (NVS)
inupadenant	iTeos Therapeutics, Inc. (ITOS)
inupadenant (EOS-850)	iTeos Therapeutics, Inc. (ITOS)
iph4502	Innate Pharma S.A. (IPHA)
jsb462	Novartis AG (NVS)
JSB462	Novartis AG (NVS)
JSB462 Dose 1 QD	Novartis AG (NVS)
jsb462 qd	Novartis AG (NVS)
KRAS TCR-Transduced PBL	Twist Bioscience Corp (TWST)
L-NMMA	ADMA BIOLOGICS, INC. (ADMA)
L-NMMA	ENANTA PHARMACEUTICALS INC (ENTA)
L-NMMA	Relay Therapeutics, Inc. (RLAY)
L-NMMA	Novartis AG (NVS)
L-NMMA	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
L-NMMA	Cidara Therapeutics, Inc. (CDTX)
lenvatinib	CG Oncology, Inc. (CGON)
Lenvatinib	Merus N.V. (MRUS)
Leronlimab	CytoDyn Inc. (CYDY)
Leucovorin	AbbVie Inc. (ABBV)
Lifileucel	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
LN-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
LN-145-S1	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Long-acting leronlimab	CytoDyn Inc. (CYDY)
Loperamide	ASTRAZENECA PLC (AZN)
lp-100	Lantern Pharma Inc. (LTRN)
lsta1	LISATA THERAPEUTICS, INC. (LSTA)
Luteinizing hormone-releasing hormone analogue	UNITED THERAPEUTICS Corp (UTHR)
Lutetium Lu 177 Dotatate	Royalty Pharma plc (RPRX)
Lymphodepletion	ENANTA PHARMACEUTICALS INC (ENTA)
m6223	GH Research PLC (GHRS)
M6223	NEKTAR THERAPEUTICS (NKTR)
Maximum Tolerated Dose of leronlimab	CytoDyn Inc. (CYDY)
Metronidazole	ARS Pharmaceuticals, Inc. (SPRY)
Metronidazole	Royalty Pharma plc (RPRX)
Metronidazole	UNITED THERAPEUTICS Corp (UTHR)
Metronidazole	Janux Therapeutics, Inc. (JANX)
mFOLFIRINOX	KYNTRA BIO INC. (KYNB)
mFOLFIRINOX	Merus N.V. (MRUS)
mFOLFIRINOX infusion	Merus N.V. (MRUS)
mfolfirinox treatment regimen	ONCOLYTICS BIOTECH INC (ONCY)
mFOLFIRINOX Treatment Regimen	KYNTRA BIO INC. (KYNB)
mFOLFOXIRI	Merus N.V. (MRUS)
mFOLFOXIRI	KYNTRA BIO INC. (KYNB)
mFOLFOXIRI	REGENXBIO Inc. (RGNX)
Mifepristone	KYNTRA BIO INC. (KYNB)
Minocycline	Structure Therapeutics Inc. (GPCR)
modified folfox6	Novartis AG (NVS)
NAI	Amneal Pharmaceuticals, Inc. (AMRX)
NAI	FATE THERAPEUTICS INC (FATE)
nal-IRI,5-fu,LV, benmelstobart, anlotinib	Merus N.V. (MRUS)
navicixizumab	OncoMed Pharmaceuticals Inc (OMED)
ngc-cap	Processa Pharmaceuticals, Inc. (PCSA)
Niraparib	IGM Biosciences, Inc. (IGMS)
nktr-255	GH Research PLC (GHRS)
nuzefatide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
ODM-201	KYNTRA BIO INC. (KYNB)
Oleclumab	ASTRAZENECA PLC (AZN)
Ompenaclid	REGENXBIO Inc. (RGNX)
Ompenaclid	ENANTA PHARMACEUTICALS INC (ENTA)
Ompenaclid	Crinetics Pharmaceuticals, Inc. (CRNX)
Ompenaclid	Merus N.V. (MRUS)
ONA-XR	Context Therapeutics Inc. (CNTX)
Onvansertib	IGM Biosciences, Inc. (IGMS)
palifosfamide	Alaunos Therapeutics, Inc. (TCRT)
panitumumab	AbbVie Inc. (ABBV)
pc14586	PMV Pharmaceuticals, Inc. (PMVP)
PD-L1 t-haNK	Amneal Pharmaceuticals, Inc. (AMRX)
PD-L1 t-haNK	FATE THERAPEUTICS INC (FATE)
pds01adc	PDS Biotechnology Corp (PDSB)
PDS01ADC	IGM Biosciences, Inc. (IGMS)
PDS01ADC	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Pegfilgrastim	KYNTRA BIO INC. (KYNB)
pelareorep	ONCOLYTICS BIOTECH INC (ONCY)
Pemetrexed	Structure Therapeutics Inc. (GPCR)
Pemetrexed	Arcus Biosciences, Inc. (RCUS)
Pemetrexed	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Pemetrexed	iTeos Therapeutics, Inc. (ITOS)
Personalized Synthetic Long Peptide Vaccine	ADMA BIOLOGICS, INC. (ADMA)
PF-08634404	Merus N.V. (MRUS)
Poly ICLC	ADMA BIOLOGICS, INC. (ADMA)
QL1706	Valneva SE (VALN)
Relatlimab	UNITED THERAPEUTICS Corp (UTHR)
Relatlimab	ENANTA PHARMACEUTICALS INC (ENTA)
RP2	ENANTA PHARMACEUTICALS INC (ENTA)
sacituzumab govitecan	GH Research PLC (GHRS)
Sacituzumab Govitecan	Crinetics Pharmaceuticals, Inc. (CRNX)
Sacituzumab Govitecan	NEKTAR THERAPEUTICS (NKTR)
Sacituzumab Govitecan	Amneal Pharmaceuticals, Inc. (AMRX)
Sacituzumab Govitecan	ADMA BIOLOGICS, INC. (ADMA)
salmonella-il2	Salspera, Inc. (TKVA)
sarilumab	REGENERON PHARMACEUTICALS, INC. (REGN)
srf617	Coherus Oncology, Inc. (CHRS)
SRF617	Arcus Biosciences, Inc. (RCUS)
SX-682	KYNTRA BIO INC. (KYNB)
Talazoparib	KYNTRA BIO INC. (KYNB)
tavo	ONCOSEC MEDICAL INC (ONCS)
temsirolimus	Black Diamond Therapeutics, Inc. (BDTX)
testosterone cypionate	KYNTRA BIO INC. (KYNB)
Testosterone cypionate	UNITED THERAPEUTICS Corp (UTHR)
Testosterone Cypionate	Janux Therapeutics, Inc. (JANX)
Testosterone enanthate	UNITED THERAPEUTICS Corp (UTHR)
Timolol	Structure Therapeutics Inc. (GPCR)
tislelizumab	Novartis AG (NVS)
tislelizumab	Novartis AG (NVS)
Tocilizumab	Merus N.V. (MRUS)
TPC	KYNTRA BIO INC. (KYNB)
trametinib	Novartis AG (NVS)
Tremelimumab	Crinetics Pharmaceuticals, Inc. (CRNX)
Tremelimumab	ADMA BIOLOGICS, INC. (ADMA)
tusamitamab ravtansine	Sanofi (SNY)
Tuvusertib	Merck & Co., Inc. (MRK)
ubamatamab	REGENERON PHARMACEUTICALS, INC. (REGN)
veledimex	Alaunos Therapeutics, Inc. (TCRT)
Veliparib	IGM Biosciences, Inc. (IGMS)
Vemurafenib	Filana Therapeutics Inc. (FLNA)
Vemurafenib	ENANTA PHARMACEUTICALS INC (ENTA)
Vincristine Sulfate Liposome	ENANTA PHARMACEUTICALS INC (ENTA)
vinorelbine	CG Oncology, Inc. (CGON)
vinorelbine	ALX ONCOLOGY HOLDINGS INC (ALXO)
vinorelbine	Cardiff Oncology, Inc. (CRDF)
Vinorelbine	ENANTA PHARMACEUTICALS INC (ENTA)
vudalimab	Xencor Inc (XNCR)
vudalimab monotherapy	Xencor Inc (XNCR)
zelenectide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
zelenectide pevedotin (formerly BT8009)	BICYCLE THERAPEUTICS PLC (BCYC)
ZEN-3694	KYNTRA BIO INC. (KYNB)
zimberelimab	Coherus Oncology, Inc. (CHRS)
Zinc gluconate	Structure Therapeutics Inc. (GPCR)
ZN-c3	Zentalis Pharmaceuticals, Inc. (ZNTL)

Phase 1(222)

Drug	Company
[177lu]lu-psma-617	Novartis AG (NVS)
[177Lu]Lu-PSMA-617	Novartis AG (NVS)
[225ac]ac-aky-2519	Aktis Oncology Inc. (AKTS)
[64cu]cu-aky-2519	Aktis Oncology Inc. (AKTS)
[68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.	UNITED THERAPEUTICS Corp (UTHR)
[68ga]ga-nns309	Novartis AG (NVS)
[68ga]ga-psma-11	Novartis AG (NVS)
177lu-dfc413	Novartis AG (NVS)
68ga-dfc413	Novartis AG (NVS)
68ga-nns309	Novartis AG (NVS)
68ga-nns309	Novartis AG (NVS)
AB680	Arcus Biosciences, Inc. (RCUS)
ABBV-969	AbbVie Inc. (ABBV)
abiraterone	AMGEN INC (AMGN)
abiraterone acetate 250 mg or	Oric Pharmaceuticals, Inc. (ORIC)
Adagrasib	IGM Biosciences, Inc. (IGMS)
adi-212	Adicet Bio, Inc. (ACET)
ADI-270	Adicet Bio, Inc. (ACET)
Alpelisib	Olema Pharmaceuticals, Inc. (OLMA)
amg 410	AMGEN INC (AMGN)
amg 436	AMGEN INC (AMGN)
amg 510	AMGEN INC (AMGN)
androgen deprivation therapy	NOVARTIS AG (NVSEF)
androgen deprivation therapy	Novartis AG (NVS)
antiemetics & antinauseants	Novartis AG (NVS)
antiemetics & antinauseants	NOVARTIS AG (NVSEF)
Apalutamide	Merus N.V. (MRUS)
Apalutamide	Janux Therapeutics, Inc. (JANX)
apalutamide 60 mg or	Oric Pharmaceuticals, Inc. (ORIC)
APX005M	IGM Biosciences, Inc. (IGMS)
arx517	Ambrx Biopharma Cayman, Inc. (AMAM)
arx517	GH Research PLC (GHRS)
ARX517	Janux Therapeutics, Inc. (JANX)
ARX517	Myovant Sciences Ltd. (MYOV)
ARX517	Royalty Pharma plc (RPRX)
ARX517	Merus N.V. (MRUS)
ARX517	ARS Pharmaceuticals, Inc. (SPRY)
ATG-022	Merck & Co., Inc. (MRK)
Atirmociclib	Merus N.V. (MRUS)
AU-007	ENANTA PHARMACEUTICALS INC (ENTA)
Avelumab	Accustem Sciences Inc. (ACUT)
AZD2936	Merus N.V. (MRUS)
Bavdegalutamide	ARVINAS, INC. (ARVN)
BET Bromodomain Inhibitor ZEN-3694	Amneal Pharmaceuticals, Inc. (AMRX)
BET Bromodomain Inhibitor ZEN-3694	FATE THERAPEUTICS INC (FATE)
bg-89894	BeOne Medicines Ltd. (ONC)
BG-89894	BeOne Medicines Ltd. (ONC)
BGB-53038	ENANTA PHARMACEUTICALS INC (ENTA)
bgb-b2033	BeOne Medicines Ltd. (BEIGF)
bgb-b2033	BeOne Medicines Ltd. (ONC)
BGB-B455	Merus N.V. (MRUS)
BI 770371	Amneal Pharmaceuticals, Inc. (AMRX)
BNT314	BioNTech SE (BNTX)
Botensilimab	AGENUS INC (AGEN)
C-TIL051	NEKTAR THERAPEUTICS (NKTR)
Cabazitaxel	Royalty Pharma plc (RPRX)
Cabazitaxel	Merus N.V. (MRUS)
Cabazitaxel	Myovant Sciences Ltd. (MYOV)
Cabazitaxel	ARS Pharmaceuticals, Inc. (SPRY)
Cabozantinib	Arcus Biosciences, Inc. (RCUS)
CAPOX	Merck & Co., Inc. (MRK)
CB-708 (ATG-037)	Calithera Biosciences, Inc. (CALA)
CCS1477	KYNTRA BIO INC. (KYNB)
Cemiplimab	Crinetics Pharmaceuticals, Inc. (CRNX)
Cetrelimab	Myovant Sciences Ltd. (MYOV)
Cetrelimab	ARS Pharmaceuticals, Inc. (SPRY)
Cetuximab	Zentalis Pharmaceuticals, Inc. (ZNTL)
chs-114	Coherus Oncology, Inc. (CHRS)
CHS-114	Merus N.V. (MRUS)
ciforadenant	Corvus Pharmaceuticals, Inc. (CRVS)
Cobicistat	KYNTRA BIO INC. (KYNB)
cosibelimab	Checkpoint Therapeutics, Inc. (CKPT)
CPI-1205	KYNTRA BIO INC. (KYNB)
CTX-8371	Compass Therapeutics, Inc. (CMPX)
Danvatirsen	Merus N.V. (MRUS)
Danvatirsen	ASTRAZENECA PLC (AZN)
day301	Day One Biopharmaceuticals, Inc. (DAWN)
Degarelix	ELI LILLY & Co (LLY)
Denosumab	Aclaris Therapeutics, Inc. (ACRS)
Divarasib	IGM Biosciences, Inc. (IGMS)
ec1169	ENDOCYTE INC (ECYT)
Edodekin alfa	ENANTA PHARMACEUTICALS INC (ENTA)
elacestrant	STEMLINE THERAPEUTICS INC (STML)
Emavusertib	Amneal Pharmaceuticals, Inc. (AMRX)
Emavusertib	Merus N.V. (MRUS)
Emavusertib	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Emavusertib	ENANTA PHARMACEUTICALS INC (ENTA)
Empagliflozin	Merus N.V. (MRUS)
Encorafenib	Zentalis Pharmaceuticals, Inc. (ZNTL)
Encorafenib	FATE THERAPEUTICS INC (FATE)
Encorafenib	ENANTA PHARMACEUTICALS INC (ENTA)
Enfortumab Vedotin	ImmunityBio, Inc. (IBRX)
Entinostat	Syndax Pharmaceuticals Inc (SNDX)
Enzalutamide	Janux Therapeutics, Inc. (JANX)
enzalutamide 40 mg capsules or 40 mg and	Oric Pharmaceuticals, Inc. (ORIC)
EO-3021	Elevation Oncology, Inc. (ELEV)
EO-3021 (also known as SYSA1801 or CPO102)	Elevation Oncology, Inc. (ELEV)
ERAS-0015	Erasca, Inc. (ERAS)
ERAS-007	Erasca, Inc. (ERAS)
ERAS-12	Erasca, Inc. (ERAS)
ERAS-3490	Erasca, Inc. (ERAS)
ERAS-4	Erasca, Inc. (ERAS)
ERAS-4001	Erasca, Inc. (ERAS)
ERAS-601	Erasca, Inc. (ERAS)
etigilimab	OncoMed Pharmaceuticals Inc (OMED)
FOLFIRI	IGM Biosciences, Inc. (IGMS)
FOLFIRI	BridgeBio Oncology Therapeutics, Inc. (BBOT)
FOLFIRI	REGENXBIO Inc. (RGNX)
FOLFIRI	ENANTA PHARMACEUTICALS INC (ENTA)
FOLFOX	REGENXBIO Inc. (RGNX)
FOLFOX	BridgeBio Oncology Therapeutics, Inc. (BBOT)
FOR46	KYNTRA BIO INC. (KYNB)
Ganitumab	Black Diamond Therapeutics, Inc. (BDTX)
gnrh antagonists	Novartis AG (NVS)
gnrh antagonists	NOVARTIS AG (NVSEF)
GNRH-A Leuprolide Acetate	ELI LILLY & Co (LLY)
gonadotropin-releasing hormone analogues	Novartis AG (NVS)
GRT-C903/GRT-R904	Filana Therapeutics Inc. (FLNA)
GRT-C903/GRT-R904	Twist Bioscience Corp (TWST)
hro761	Novartis AG (NVS)
hro761	NOVARTIS AG (NVSEF)
IDE-161	IDEAYA Biosciences, Inc. (IDYA)
ifx-hu2.0	Tyra Biosciences, Inc. (TYRA)
Inavolisib	Merus N.V. (MRUS)
individualized anti-tumor new antigen iNeo-Vac-R01 injection	KYNTRA BIO INC. (KYNB)
inr731	Novartis AG (NVS)
inr731	NOVARTIS AG (NVSEF)
jnj-101556143	GH Research PLC (GHRS)
JNJ-78278343	KYNTRA BIO INC. (KYNB)
JNJ-78278343	Merus N.V. (MRUS)
JNJ-78278343	Myovant Sciences Ltd. (MYOV)
JNJ-78278343	Royalty Pharma plc (RPRX)
JNJ-78278343	ARS Pharmaceuticals, Inc. (SPRY)
JNJ-89402638	BridgeBio Oncology Therapeutics, Inc. (BBOT)
JNJ-89402638	ENANTA PHARMACEUTICALS INC (ENTA)
JNJ-89402638	REGENXBIO Inc. (RGNX)
JNJ-89402638	IGM Biosciences, Inc. (IGMS)
JNJ-89402638	Merus N.V. (MRUS)
JSB462 QD	Merus N.V. (MRUS)
kzr-261	Kezar Life Sciences, Inc. (KZR)
lava-1207	LAVA Therapeutics NV (LVTX)
lava-1266	LAVA Therapeutics NV (LVTX)
lava-1427	LAVA Therapeutics NV (LVTX)
Leucovorin Calcium	ADMA BIOLOGICS, INC. (ADMA)
Leucovorin Calcium	CURIS INC (CRIS)
ln-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
LPM6690176	IGM Biosciences, Inc. (IGMS)
LY4050784	ELI LILLY & Co (LLY)
ly4052031	ELI LILLY & Co (LLY)
LY4101174	ELI LILLY & Co (LLY)
lymphocyte immune globulin	ENANTA PHARMACEUTICALS INC (ENTA)
me-344	Lite Strategy, Inc. (LITS)
MEDI5752	Merus N.V. (MRUS)
mFOLFIRINOX	Aclaris Therapeutics, Inc. (ACRS)
MRG007	ArriVent BioPharma, Inc. (AVBP)
mvt-1075	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
mvt-2163	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
nana-val	Viracta Therapeutics, Inc. (VIRX)
neo-pv-01	Neon Therapeutics, Inc. (NTGN)
ngm438	NGM BIOPHARMACEUTICALS INC (NGM)
ngm831	NGM BIOPHARMACEUTICALS INC (NGM)
Oleclumab	Merus N.V. (MRUS)
ONT01	ENANTA PHARMACEUTICALS INC (ENTA)
OP-3136	Olema Pharmaceuticals, Inc. (OLMA)
oric-533	Oric Pharmaceuticals, Inc. (ORIC)
oric-944	Oric Pharmaceuticals, Inc. (ORIC)
ORIC-944	KYNTRA BIO INC. (KYNB)
panitumumab	AMGEN INC (AMGN)
Pemetrexed	ADMA BIOLOGICS, INC. (ADMA)
Peposertib	Merus N.V. (MRUS)
Peposertib	Accustem Sciences Inc. (ACUT)
pf-06821497	PFIZER INC (PFE)
PH FDC SC	ENANTA PHARMACEUTICALS INC (ENTA)
Pidnarulex	Crinetics Pharmaceuticals, Inc. (CRNX)
Pumitamig	Merus N.V. (MRUS)
Quemliclustat	Arcus Biosciences, Inc. (RCUS)
Relacorilant	KYNTRA BIO INC. (KYNB)
rinzimetostat	Oric Pharmaceuticals, Inc. (ORIC)
RP3	Replimune Group, Inc. (REPL)
Sacituzumab Govitecan	Merus N.V. (MRUS)
sar408701	Sanofi (SNY)
sar441000	Sanofi (SNY)
Selicrelumab	Merus N.V. (MRUS)
SGN-LIV1A	Merus N.V. (MRUS)
sqz-aac-hpv	SQZ Biotechnologies Co (SQZB)
ST101	Myovant Sciences Ltd. (MYOV)
ST101	Merus N.V. (MRUS)
ST101	Royalty Pharma plc (RPRX)
ST101	PTC THERAPEUTICS, INC. (PTCT)
ST101	Janux Therapeutics, Inc. (JANX)
SY-5609	IGM Biosciences, Inc. (IGMS)
tagmokitug	Coherus Oncology, Inc. (CHRS)
TAK-188	Merus N.V. (MRUS)
tazemetostat	Epizyme, Inc. (EPZM)
tbio-4101	GH Research PLC (GHRS)
tcellvax	Regen BioPharma Inc (RGBPP)
Temozolomide	Myovant Sciences Ltd. (MYOV)
Temozolomide	Royalty Pharma plc (RPRX)
Temozolomide	Janux Therapeutics, Inc. (JANX)
Tinengotinib	Royalty Pharma plc (RPRX)
Tinengotinib	Janux Therapeutics, Inc. (JANX)
Tinengotinib	Myovant Sciences Ltd. (MYOV)
Tinengotinib	ARS Pharmaceuticals, Inc. (SPRY)
tpx-0131	Turning Point Therapeutics, Inc. (TPTX)
TQB3201 tablets	KYNTRA BIO INC. (KYNB)
Tulmimetostat DL1 QD	Merus N.V. (MRUS)
Tulmimetostat DL2 QD	Merus N.V. (MRUS)
Tulmimetostat DL3 QD	Merus N.V. (MRUS)
Tulmimetostat Doses 1 or 2 QD	Merus N.V. (MRUS)
Tulmimetostat RP2D QD	Merus N.V. (MRUS)
TYRA-430	Tyra Biosciences, Inc. (TYRA)
wtx-124	Werewolf Therapeutics, Inc. (HOWL)
xaluritamig	AMGEN INC (AMGN)
XB010	EXELIXIS, INC. (EXEL)
XNW5004	KYNTRA BIO INC. (KYNB)
Zavedos®	Merus N.V. (MRUS)
Zidesamtinib	Nuvalent, Inc. (NUVL)
Zoledronic acid	Aclaris Therapeutics, Inc. (ACRS)
Zumsemetinib	Aclaris Therapeutics, Inc. (ACRS)
Zunsemetinib	Tango Therapeutics, Inc. (TNGX)
Zunsemetinib	KYNTRA BIO INC. (KYNB)
Zunsemetinib	Merus N.V. (MRUS)

Preclinical(17)

Drug	Company
225ac-psma-62	POINT Biopharma Global Inc. (PNT)
adct-241	ADC Therapeutics SA (ADCT)
ATNM-400	Actinium Pharmaceuticals, Inc. (ATNM)
BP1003	BIO-PATH HOLDINGS, INC. (BPTH)
ca4p	Oncotelic Therapeutics, Inc. (OTLC)
ck-103	Checkpoint Therapeutics, Inc. (CKPT)
CLD-400 (RTNova)	Calidi Biotherapeutics Inc. (CLDI)
cypcaps	PharmaCyte Biotech, Inc. (PMCB)
duet-02	Scopus BioPharma Inc. (SCPS)
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)
lava-1433	LAVA Therapeutics NV (LVTX)
mena-targeted therapeutic candidates	METASTAT, INC. (MTST)
p-psma-allo1	Poseida Therapeutics, Inc. (PSTX)
pnt2001	POINT Biopharma Global Inc. (PNT)
pop1 program	Propanc Biopharma, Inc. (PPCB)
SBI-183	AXIM BIOTECHNOLOGIES, INC. (AXIM)
SPX-1009	AXIM BIOTECHNOLOGIES, INC. (AXIM)

Unknown(10)

Drug	Company
archival tumor dna sequencing	GH Research PLC (GHRS)
degarelix	PFIZER INC (PFE)
goserelin	PFIZER INC (PFE)
liquid biopsy	GH Research PLC (GHRS)
lutetium-177	PFIZER INC (PFE)
non-SGLT2 inhibitors	ENANTA PHARMACEUTICALS INC (ENTA)
Precise Liquid	MYRIAD GENETICS INC (MYGN)
radium-223	PFIZER INC (PFE)
sm-88	TYME TECHNOLOGIES, INC. (TYME)
triptorelin	PFIZER INC (PFE)

BLA Filed(1)

Drug	Company
larotrectinib	LOXO ONCOLOGY, INC. (LOXO)

Early Phase 1(10)

Drug	Company
Curcumin	Merus N.V. (MRUS)
Encorafenib	Amneal Pharmaceuticals, Inc. (AMRX)
experimental	VERTEX PHARMACEUTICALS INC / MA (VRTX)
Panitumumab	Amneal Pharmaceuticals, Inc. (AMRX)
Sotorasib	Amneal Pharmaceuticals, Inc. (AMRX)
Sotorasib	IGM Biosciences, Inc. (IGMS)
Trifluridine/tipiracil	Amneal Pharmaceuticals, Inc. (AMRX)
Trifluridine/tipiracil	IGM Biosciences, Inc. (IGMS)
Tucatinib	IGM Biosciences, Inc. (IGMS)
Tucatinib	Amneal Pharmaceuticals, Inc. (AMRX)

N/A(2)

Drug	Company
Pazopanib	Black Diamond Therapeutics, Inc. (BDTX)
Polyethylene Glycol	Black Diamond Therapeutics, Inc. (BDTX)

Phase 1/Phase 2(81)

Drug	Company
[177lu]lu-dota-tate	Novartis AG (NVS)
[177lu]lu-neob	Novartis AG (NVS)
[68ga]ga-dota-tate	Novartis AG (NVS)
[68Ga]Ga-DOTA-TATE	Novartis AG (NVS)
[68ga]ga-neob	Novartis AG (NVS)
[68ga]ga-neob	Novartis AG (NVS)
177lu-fap-2286	Novartis AG (NVS)
68ga-fap-2286	Novartis AG (NVS)
abiraterone	CONSTELLATION PHARMACEUTICALS INC (CNST)
abiraterone	Novartis AG (NVS)
abiraterone	VERTEX PHARMACEUTICALS INC / MA (VRTX)
amo959	Novartis AG (NVS)
AMO959	Novartis AG (NVS)
ARV-110	ARVINAS, INC. (ARVN)
arv-766 + abiraterone part c&d	Novartis AG (NVS)
arv-766 part a&b	Novartis AG (NVS)
avelumab	VACCINEX, INC. (VCNX)
Binimetinib	IDEAYA Biosciences, Inc. (IDYA)
BNT324	BioNTech SE (BNTX)
bpx-601	BELLICUM PHARMACEUTICALS, INC (BLCM)
bpx-603	BELLICUM PHARMACEUTICALS, INC (BLCM)
cemiplimab regn2810	Sanofi (SNY)
cetuximab	Novartis AG (NVS)
Chemotherapy	Merus N.V. (MRUS)
cpi-1205	CONSTELLATION PHARMACEUTICALS INC (CNST)
cpi-1205	VERTEX PHARMACEUTICALS INC / MA (VRTX)
cr-001	CRESCENT BIOPHARMA, INC. (CBIO)
dcc-3116	Deciphera Pharmaceuticals, Inc. (DCPH)
exicorilant	CORCEPT THERAPEUTICS INC (CORT)
ft-7051	Forma Therapeutics Holdings, Inc. (FMTX)
IDE196	IDEAYA Biosciences, Inc. (IDYA)
iph4502	Innate Pharma SA (IPHYF)
jdq443	Novartis AG (NVS)
jsb462 dose 1 qd	Novartis AG (NVS)
jsb462 dose 2 qd	Novartis AG (NVS)
JSB462 Dose 2 QD	Novartis AG (NVS)
JSB462 QD	Novartis AG (NVS)
m-FOLFOX-6 regimen	Arcus Biosciences, Inc. (RCUS)
MCLA-129	Merus N.V. (MRUS)
micvotabart pelidotin	Pyxis Oncology, Inc. (PYXS)
mrtx1719	Mirati Therapeutics, Inc. (MRTX)
nc762	NextCure, Inc. (NXTC)
opnurasib	NOVARTIS AG (NVSEF)
opnurasib	Novartis AG (NVS)
oric-114 dose 1 + amivantamab	Oric Pharmaceuticals, Inc. (ORIC)
oric-114 dose 2 + amivantamab	Oric Pharmaceuticals, Inc. (ORIC)
oric-114 dose 3 + amivantamab	Oric Pharmaceuticals, Inc. (ORIC)
Osimertinib	Merus N.V. (MRUS)
part 1	GH Research PLC (GHRS)
part 2	GH Research PLC (GHRS)
phase 1b	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
regn15505+regn4336	REGENERON PHARMACEUTICALS, INC. (REGN)
regn7075	REGENERON PHARMACEUTICALS, INC. (REGN)
Regorafenib	Arcus Biosciences, Inc. (RCUS)
ryz101	RayzeBio, Inc. (RYZB)
sd-101	TriSalus Life Sciences Inc. (TLSI)
son-1210	SONNET BIOTHERAPEUTICS HOLDINGS, INC. (BURG)
surufatinib and tislelizumab _ part 1	HUTCHMED (China) Limited (HCM)
surufatinib and tislelizumab _ part 2	HUTCHMED (China) Limited (HCM)
SX-682	UNITED THERAPEUTICS Corp (UTHR)
tislelizumab	HUTCHMED (China) Limited (HCM)
tno155	Novartis AG (NVS)
tno155	Novartis AG (NVS)
tqb2922	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
trifluridine tipiracil	ONCOLYTICS BIOTECH INC (ONCY)
tulmimetostat	Novartis AG (NVS)
Tulmimetostat	Novartis AG (NVS)
tulmimetostat dl1 qd	Novartis AG (NVS)
Tulmimetostat DL1 QD	Novartis AG (NVS)
tulmimetostat dl2 qd	Novartis AG (NVS)
Tulmimetostat DL2 QD	Novartis AG (NVS)
tulmimetostat dl3 qd	Novartis AG (NVS)
Tulmimetostat DL3 QD	Novartis AG (NVS)
tulmimetostat doses 1 or 2 qd	Novartis AG (NVS)
Tulmimetostat Doses 1 or 2 QD	Novartis AG (NVS)
tulmimetostat rp2d qd	Novartis AG (NVS)
Tulmimetostat RP2D QD	Novartis AG (NVS)
VMT-α-NET	Perspective Therapeutics, Inc. (CATX)
vociprotafib	Sanofi (SNY)
vociprotafib	Sanofi (SNYNF)
wtx-330	Werewolf Therapeutics, Inc. (HOWL)

Phase 2/Phase 3(16)

Drug	Company
CAPOX	BRISTOL MYERS SQUIBB CO (BMY)
Crizotinib	IDEAYA Biosciences, Inc. (IDYA)
Dacarbazine	IDEAYA Biosciences, Inc. (IDYA)
enfortumab vedotin-ejfv	Mirati Therapeutics, Inc. (MRTX)
ficerafusp alfa	Bicara Therapeutics Inc. (BCAX)
FOLFIRI	BRISTOL MYERS SQUIBB CO (BMY)
FOLFOX	BRISTOL MYERS SQUIBB CO (BMY)
folinic acid/ leucovorina	AbbVie Inc. (ABBV)
granite	Gritstone bio, Inc. (GRTS)
ifx-hu2.0	TuHURA Biosciences, Inc./NV (HURA)
sitravatinib	Mirati Therapeutics, Inc. (MRTX)
surufatinib	HUTCHMED (China) Limited (HCM)
surufatinib combined with camrelizumab	HUTCHMED (China) Limited (HCM)
surufatinib combined with camrelizumab	HUTCHMED (China) Ltd (HMDCF)
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)
tovecimig (CTX-009)	Compass Therapeutics, Inc. (CMPX)

Phase 4(54)

Drug	Company
[177lu]lu-neob	Novartis AG (NVS)
5-flurorouracil	Merus N.V. (MRUS)
5-FU	IGM Biosciences, Inc. (IGMS)
abiraterone	PFIZER INC (PFE)
abiraterone	ASTRAZENECA PLC (AZN)
Abiraterone	KYNTRA BIO INC. (KYNB)
Abiraterone acetate	KYNTRA BIO INC. (KYNB)
Abiraterone acetate 250 mg or 500 mg tablets	KYNTRA BIO INC. (KYNB)
Abiraterone Oral Tablet	KYNTRA BIO INC. (KYNB)
adavosertib 150 mg bd + olaparib 200 mg bd	ASTRAZENECA PLC (AZN)
Androgen-deprivation Therapy	Janux Therapeutics, Inc. (JANX)
Apalutamide	UNITED THERAPEUTICS Corp (UTHR)
Apalutamide	Royalty Pharma plc (RPRX)
Apalutamide	ASTRAZENECA PLC (AZN)
Binimetinib	Novartis AG (NVS)
BMS-986504	BRISTOL MYERS SQUIBB CO (BMY)
CAPOX chemotherapy	Merus N.V. (MRUS)
ceralasertib 160 mg od + olaparib continuous 300 mg bd	ASTRAZENECA PLC (AZN)
Cetuximab	IGM Biosciences, Inc. (IGMS)
Cetuximab wkly	IGM Biosciences, Inc. (IGMS)
Chemotherapy Regimen	Merus N.V. (MRUS)
Concurrent chemotherapy	Merus N.V. (MRUS)
Conditioning chemotherapy	Merus N.V. (MRUS)
Dabrafenib	Novartis AG (NVS)
Dabrafenib plus Trametinib	Novartis AG (NVS)
Darolutamide	KYNTRA BIO INC. (KYNB)
Darolutamide	ASTRAZENECA PLC (AZN)
Darolutamide plus ADT treatment	Myovant Sciences Ltd. (MYOV)
Enzalutamide	Royalty Pharma plc (RPRX)
Enzalutamide	ASTRAZENECA PLC (AZN)
Enzalutamide Oral Capsule	KYNTRA BIO INC. (KYNB)
Enzalutamide Soft Capsules	KYNTRA BIO INC. (KYNB)
Enzalutamide；Abiraterone	KYNTRA BIO INC. (KYNB)
FOLFOX chemotherapy	Merus N.V. (MRUS)
Folinic acid	IGM Biosciences, Inc. (IGMS)
Investigator's Choice of Chemotherapy	Merus N.V. (MRUS)
Leucovorin Calcium	IGM Biosciences, Inc. (IGMS)
Lutetium Lu 177 Vipivotide Tetraxetan	Novartis AG (NVS)
Lymphodepletion Chemotherapy	Merus N.V. (MRUS)
Memantine Hydrochloride	KYNTRA BIO INC. (KYNB)
NAH therapy	KYNTRA BIO INC. (KYNB)
Neoadjuvant olaparib	ASTRAZENECA PLC (AZN)
Olaparib	ASTRAZENECA PLC (AZN)
olaparib continuous 300 mg bd	ASTRAZENECA PLC (AZN)
Pemetrexed	ASTRAZENECA PLC (AZN)
Platinum chemotherapy	Merus N.V. (MRUS)
Radium-223 dichloride	KYNTRA BIO INC. (KYNB)
rezvilutamide	ASTRAZENECA PLC (AZN)
Rezvilutamide Tablets	KYNTRA BIO INC. (KYNB)
saruparib	ASTRAZENECA PLC (AZN)
Single Cycle Intensive Chemotherapy	Merus N.V. (MRUS)
Tandem 3 Cycle Intensive Chemotherapy	Merus N.V. (MRUS)
toripalimab	Coherus Oncology, Inc. (CHRS)
Vancomycin and Tobramycin	UNITED THERAPEUTICS Corp (UTHR)

Compare drugs

abiraterone vs ABRAXANE abiraterone vs aBSI (Automated Bone Scan Index)abiraterone vs afinitor

Frequently asked questions

How many drugs are in development for Metastatic?

BioSniper tracks 990 drugs in development for Metastatic across 204 companies.

How many clinical trials target Metastatic?

There are 3 clinical trials targeting Metastatic tracked by BioSniper.

Deep-dive into Metastatic

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis